Search
for
Sort by
Research 241–270 of 857
- Endocrine control of benign prostatic hyperplasia
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Dermatologic manifestations of endocrine disorders
- Drug Reactions Affecting Hair: Diagnosis
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Current evaluation of amenorrhea
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Adverse effects of common medications on male fertility
- Emerging medication for the treatment of male hypogonadism
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Safety of dermatologic medications in pregnancy and lactation
- Polycystic ovary syndrome and impact on health
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Age-induced hair greying - the multiple effects of oxidative stress
- Telogen effluvium
- The control of hair growth: An overview
- Gene Expression During Drosophila Wing Morphogenesis and Differentiation
- Menopause and aging, quality of life and sexuality
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Prolactin delays hair regrowth in mice
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin®, on the healing of skin wound
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Mood disorders and quality of life in polycystic ovary syndrome